How AI Is Transforming Rare Disease Research
Vanessa Almendro-Navarro and Mary Carmichael of Danaher Corporation joined MiraKare founder Vik Sharma to explain how artificial intelligence gives an exponential boost to rare disease research and caregiving.
Rare Disease Families Need Screening, Genetic Counseling, Advocates Say
Early Detection and Counseling are Game Changers for Rare Metabolic Disorders
Jana Monaco sees the different outcomes that screening and counseling yielded for two of her children living with isovaleric acidemia.
Connecting Biotech’s Promise with Real Progress in the Rare Disease Realm
James Levine of Fondation Ipsen hopes international journalists amplify scientific innovation for the 300 million people with rare diseases.
AI and Health Care
Using Data to Steer Health Outcomes
Billions of bytes of data can help health professionals identify and treat people who are at risk.
Precision Medicine and Psychiatry
Epigenetics
Precision Medicine and Cancer
Pharmacogenomics: The Basics
Precision Medicine and Dementia
Big Data and Genomics
Precision Medicine 101
Inside the Mayo Clinic Biobank
The Business of Precision Medicine
Biomedical Ethics
Diagnostic Odysseys
Imaging Technologies
The Superhighway of Your DNA
Human Genome Project to NIH
